Investigation Of Burnout Levels And Their Relationship With Serum S100B Levels İn Emergency Department Staff

Yıl 2024, Cilt: 6 Sayı: 2, 58 - 61, 05.09.2024

Gamze Bozkuş , Bedia Gülen

https://doi.org/10.55994/ejcc.1539313

Öz

Objective: Burnout syndrome is characterized by physical, emotional, and mental symptoms. This study aims to investigate the relationship between S100B protein levels and burnout syndrome and depression in emergency department staff.
Materials and Methods: The study included nurses and paramedics working in the emergency department of our university hospital. Depression levels and burnout severity were assessed using the Beck Depression Inventory (BDI) and the Maslach Burnout Inventory (MBI) before shifts. Blood samples were collected before and after shifts to measure S100B levels. Results were compared with S100B levels, and data were analyzed using SPSS.
Results: The study included 29 nurses (65.9%) and 15 paramedics (34.1%). Participants had an average emotional exhaustion score of 27.2 ± 7.4 (median (IQ) = 28 (22.3-33.0)), depersonalization score of 11.3 ± 4.1 (median (IQ) = 11 (9.0-13.8)), and personal accomplishment deficiency score of 30.0 ± 6.4 (median (IQ) = 28.5 (25.0-35.8)). The average BDI score was 34.4 ± 8.0 (median (IQ) = 33.5 (29.0-36.8)). Pre-shift S100B levels were 77.0 ± 21.8 (median (IQ) = 72.4 (66.4-80.6)), while post-shift S100B levels were 113.0 ± 129.6 (median (IQ) = 72.5 (65.7-87.8)). A statistically significant increase in S100B levels was observed between pre- and post-shift (p = 0.046). However, there was no significant correlation between post-shift serum S100B levels and emotional exhaustion, depersonalization, personal accomplishment deficiency, or BDI scores (p > 0.05).
Conclusion: Although there is a significant change in S100B levels before and after shifts, S100B levels are not correlated with BDI scores and MBI dimensions. These findings suggest that while S100B may not be a long-term predictor of burnout and depression in emergency staff, it could be used to determine shift durations for effective management.

Anahtar Kelimeler

Burnout, emergency, S100B

Etik Beyan

Bezmialem Vakıf University Ethics Committee

Destekleyen Kurum

nope

Kaynakça

• 1. Sturgess, J., Poulsen, A., The Prevalence of burnout inoccupationalt herapists. Occup. Ther. Ment. Health 3 (4), 47- 60. 1983.
• 2. Bauer J, Hafner S, Kachele H, Wirsching M, Dahlbender RW. The burn-out syndrome and restoring mental health at the working place. Psychother Psychosom Med Psychol. 2003; 53(5):213-22
• 3. Serinken M, Ergör A, Çımrın AH, Ersoy G. İzmir İlindeki Acil Servis Hekimlerinin Tükenme Düzeyleri. Toplum ve Hekim, Temmuz-Ağustos, 18 (4): 293-299. 2003
• 4. Kalia M, Costa E Silva J2. Biomarkers of psychiatric diseases: current status and future prospects. Metabolism. 2015 Mar; 64(3 Suppl 1):S11-5
• 5. M.J. Berridge, P. Lipp, M.D. Bootman, The versatility and universality of calcium signalling, Nat. Rev. Mol. Cell Biol. 1, 11– 21, 2000
• 6. S. Rety, D. Osterloh, J.-P. Arie´, S. Tabaries, J. Seeman, F. Russo-Marie, V. Gerke, A. Lewit-Bentley, Structural basis of the Ca2+-dependent association between S100 (S100A11) and its target, the N-terminal part of annexin I, Structure 8, 175–184,2000
• 7. R.R. Rustandi, D.M. Baldisseri, D.J. Weber, Structure of the negative regulatory domain of p53 bound to S100B, Nat. Struct. Biol. 7,570–57, 2000
• 8. Çevik A. Acil servis hekimleri ve ‘’burn out’’ sendromu. Acil Tıp Dergisi, 3. Acil Tıp Sempozyumu özel sayısı, 2000, s 282-288.
• 9. Kaynak 2Moss M, Good VS, Gozal D, Kleinpell R, Sessler CN. A Critical Care Societies Collaborative Statement: Burnout Syndrome in Critical Care Health-care Professionals. A Call for Action. Moss M, Good VS, Gozal D, Kleinpell R, Sessler CN. Am J Respir Crit Care Med. 2016 Jul 1;194(1):106-13.
• 10. Ahmadi O, Azizkhani R, Basravi M. Correlation between workplace and occupational burnout syndrome in nurses. Adv Biomed Res. 2014 Jan 24;3.44. doi: 10.4103/2277-9175,125751. eCollection 2014.
• 11. Kalia M, Costa E Silva J2. Biomarkers of psychiatric diseases: current status and future prospects. Metabolism. 2015 Mar; 64(3 Suppl 1):S11-5. Doi: 10,1016/j.metabol.2014.10.026. Epub 2014 Oct 30.
• 12. Gulen B, Serinken M, Eken C, Karcıoglu Ö, Kucukdagli OT, Kilic E, Akpinar G, Nogay S, Kuh M. Serum S100B as a Surrogate Biomarker in the Diagnoses of Burnout and Depression in Emergency Medicine Residents. Acad Emerg Med. 2016 Jul; 23(7):786-9. doi: 10,1111/acem.12973. Epub 2016 Jun 16.
• 13. Ambrée O1, Bergink V2, Grosse L2, Alferink J2, Drexhage HA2, Rothermundt M2, Arolt V2, Birkenhäger TK2. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression. Int J Neuropsychopharmacol. 2015 Sep 12. pii: pyv103. doi: 10,1093/ijnp/pyv103. [Epub ahead of print]
• 14. Schroeter M. L. Sacher J. Steiner J. Schoenknecht P. Mueller K. (2013). Serum S100B represents a new biomarker for mood disorders. Curr. Drug Targets 14, 1237–1248.
• 15. Polyakova M. Stuke K. Schuemberg K. Mueller K. Schoenknecht P. Schroeter M. L. (2015). BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis. J. Affect. Disord. 174, 432–440.
• 16. Ambrée O, Bergink V, Grosse L, Alferink J, Drexhage HA, Rothermundt M, Arolt V, Birkenhäger TK. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression. Int J Neuropsychopharmacol. 2015 Sep 12. pii: pyv103. doi: 10,1093/ijnp/pyv103).